Xtra Concentrate
Natural health product licensed in Canada
- Other names
- Xtra Concentrate-P2
- Licence holder
- Univera Canada Ltd.
- NPN or DIN-HM
- 80051616
- Status
- Active licence
- Licence date
- 10 June 2014
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille Extraction ratio : 4:1 Dry plant equivalent : 880 mg Potency : 25 % Catechins | 220 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 8 % Caffeine | Not specified | Not calculated |
| Ophiocordyceps sinensis Source : Mycelia Extraction ratio : 4:1 Dry plant equivalent : 500 mg | 125 mg | Not calculated |
| Niacine Source : Niacine | 5 mg | Not calculated |
| Vitamine B6 Source : 5-phosphate de pyridoxal | 2.6 mg | Not calculated |
| 3-Pyridinecarboxamide Source : Niacinamide | 12.5 mg | Not calculated |
| Alpha-cétoglutarate de L(+)-ornithine Source : Ornicétil | 150 mg | Not calculated |
| Acide 3,4,5-Trihydroxybenzoïque Source : Acide gallique | 220 mg | Not calculated |
| Withania somnifera Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 600 mg | 150 mg | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 150 mg | Not calculated |
| Senegalia catechu Source : Stem heartwood Extraction ratio : 20:1 Dry plant equivalent : 425 mg Potency : 65 % (+)-Catechin | 21.25 mg | Not calculated |
| Scutellaria baicalensis Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg Potency : 75 % Baicalin | 100 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extraction ratio : 50:1 Dry plant equivalent : 2,000 mg Potency : 24 % Flavonoid glycosides | 40 mg | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Acide DL-alpha lipoÏque Source : Acide DL-alpha-lipoÏque | 10 mg | Not calculated |
| Rhodiola rosea Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg Potency : 3 % Rosavin | 150 mg | Not calculated |
| Rhodiola rosea Source : Racine Potency : 1 % Salidroside | Not specified | Not calculated |
Non-medicinal ingredients
rouge de betterave, Concentrated Vaccinium corymbosum (blueberry) fruit juice, Acide citrique, Eau purifiée, Benzoate de sodium, Benzoate de potassium, Aloe Barbadensis Leaf Extract, Extrait de fruit de Siraitia grosvenorii, Jus concentré de raisin, Maltodextrine, Jus de fruit de canneberge, Sucralose, Prunus Avium (Sweet Cherry) fruit extract, d-Sorbitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Portion(s) | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain associated with osteoarthritis. Helps to enhance memory and cognitive function in adults. Source of antioxidants for the maintenance of good health. A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. (Used in Herbal Medicine) (as an adaptogen) (to) help(s) (to) temporary relieve symptoms of stress (such as mental fatigue and sensation of weakness). (Used in Herbal Medicine) (to) help(s) support cognitive function (such as mental focus and mental stamina). Provides antioxidants. Argi nine is a non-essential amino acid that is involved in protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051616
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.